Key Statistics for 4530
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (JPY) (ttm)
|Est. EPS (JPY) (02/2014)
|Est. PEG Ratio
|Market Cap (M JPY)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (JPY)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 4530
- Net Income (M/JPY)
HISAMITSU PHARMACEUTICAL CO., INC. produces and sells pharmaceutical products. The Company's main product is anti-inflammatory analgesic plasters and poultices sold under the brand name Salonpas. Hisamitsu Pharmaceutical exports its products to North America and Southeast Asia. The Company also researches and develops antibacterial products through its related company, RRF.
More Company Profile & Key Executives for 4530
|Hirotaka NakatomiPresident/CEO||Kazuyo NakatomiSenior Managing Director|
|Kensaku SueyasuSenior Managing Director||Tetsuo AkiyamaManaging Director|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.